Cargando…
Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study
A case is described here of drug-induced immune hemolytic anemia (DIIHA) due to cefotetan administered to a post-partum woman who received the drug for infection prophylaxis at the time of caesarean section. Renewed fatal hemolysis occurred when the drug was given a second time 12 days after the fir...
Autor principal: | Perkins, Jim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798759/ https://www.ncbi.nlm.nih.gov/pubmed/20041074 http://dx.doi.org/10.4103/0973-6247.39507 |
Ejemplares similares
-
Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration
por: Park, Seha, et al.
Publicado: (2021) -
A Repeat Case of Cefotetan-Induced Hemolytic Anemia in a Surgical Patient
por: Gallagher, Alayna, et al.
Publicado: (2022) -
Immunologic Evaluation of Patients with Cefotetan-Induced Anaphylaxis
por: Nam, Young-Hee, et al.
Publicado: (2015) -
Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case
por: Dacha, Sunil, et al.
Publicado: (2010) -
Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor
por: Haley, Kristina M, et al.
Publicado: (2014)